echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: Study on the effect of BNT162b2 and mRNA-1273 vaccines in the first-line healthcare population

    NEJM: Study on the effect of BNT162b2 and mRNA-1273 vaccines in the first-line healthcare population

    • Last Update: 2021-12-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Medical staff is a high-risk group of new coronary pneumonia .


    New Coronary Pneumonia FDA researchers recently announced the effectiveness of the new coronary pneumonia vaccine in the first-line medical care population


    This study is a case-control study involving medical staff in 25 states in the United States


    The study included 1482 confirmed cases and 3449 control participants


    The effectiveness of the BNT162b2 vaccine after partial vaccination was 77.


    Changes in protective effect over time after completing the second dose of vaccination

    Changes in the protective effect over time after completing the second dose of vaccination Changes in the protective effect over time after completing the second dose of vaccination

    In the real environment of front-line medical care, the effects of BNT162b2 and mRNA-1273 vaccines have been fully verified, and the vaccine effects are not affected by age and race


    In the real environment of front-line medical care, the effects of BNT162b2 and mRNA-1273 vaccines have been fully verified, and the vaccine effects are not affected by age and race


    Original source:

    Tamara Pilishvili et al.


    Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.